Hoth Therapeutics Files 8-K
Ticker: HOTH · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1711786
| Field | Detail |
|---|---|
| Company | Hoth Therapeutics, Inc. (HOTH) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: HOTH
TL;DR
HOTH filed an 8-K on 6/20 for events on 6/18 - details pending.
AI Summary
Hoth Therapeutics, Inc. filed an 8-K on June 20, 2025, reporting other events and financial statements as of June 18, 2025. The filing does not contain specific details about the nature of these events or financial figures.
Why It Matters
This 8-K filing indicates that Hoth Therapeutics has reported significant events and financial statements, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and financial statements without immediate disclosed material changes.
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- June 20, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- 1177 Avenue of the Americas (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Hoth Therapeutics in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
What is the significance of the 'Financial Statements and Exhibits' being filed?
The filing indicates that financial statements and exhibits are being submitted, but the specific content or financial figures are not detailed in the provided excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 18, 2025.
What is Hoth Therapeutics, Inc.'s state of incorporation and principal executive office location?
Hoth Therapeutics, Inc. is incorporated in Nevada and its principal executive offices are located at 1177 Avenue of the Americas, 5th Floor, Suite 066, New York, NY 10036.
What is the SEC file number and CIK for Hoth Therapeutics, Inc.?
The SEC file number for Hoth Therapeutics, Inc. is 001-38803, and its Central Index Key (CIK) is 0001711786.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Hoth Therapeutics, Inc. (HOTH).